The global market for Cyclosporine A API is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Cyclosporine A API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Cyclosporine A API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Cyclosporine A API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Cyclosporine A API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Cyclosporine A API players cover Hangzhou Longshine Bio-Tech, Hangzhou Zhongmei Huadong Pharmaceutical, Zhejiang Ruibang Laboratories, North China Pharmaceutical Huasheng Co Ltd. and ChemWerth Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Cyclosporine A API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Cyclosporine A API market, with both quantitative and qualitative data, to help readers understand how the Cyclosporine A API market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Tons.
Market Segmentation:
The study segments the Cyclosporine A API market and forecasts the market size by Purity (0.95, 0.98 and 0.99), by Application (Medical Pharmaceutical and Scientific Research.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by purity
0.95
0.98
0.99
Others
Segmentation by application
Medical Pharmaceutical
Scientific Research
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Hangzhou Longshine Bio-Tech
Hangzhou Zhongmei Huadong Pharmaceutical
Zhejiang Ruibang Laboratories
North China Pharmaceutical Huasheng Co Ltd.
ChemWerth Inc
AbbVie Inc
Catalent Pharma Solutions
Teva API
Actavis Inc.
Apotex Fermentation Inc.
CKD Bio Corporation
Concord Biotech
JOYANG LABORATORIES
Novartis Pharmaceuticals Corporation
Tecoland Corporation
Chapter Introduction
Chapter 1: Scope of Cyclosporine A API, Research Methodology, etc.
Chapter 2: Executive Summary, global Cyclosporine A API market size (sales and revenue) and CAGR, Cyclosporine A API market size by region, by purity, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Cyclosporine A API sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Cyclosporine A API sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by purity, and purity.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Cyclosporine A API market size forecast by region, by country, by purity, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Hangzhou Longshine Bio-Tech, Hangzhou Zhongmei Huadong Pharmaceutical, Zhejiang Ruibang Laboratories, North China Pharmaceutical Huasheng Co Ltd., ChemWerth Inc, AbbVie Inc, Catalent Pharma Solutions, Teva API and Actavis Inc., etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cyclosporine A API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Cyclosporine A API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Cyclosporine A API by Country/Region, 2017, 2022 & 2028
2.2 Cyclosporine A API Segment by Purity
2.2.1 0.95
2.2.2 0.98
2.2.3 0.99
2.2.4 Others
2.3 Cyclosporine A API Sales by Purity
2.3.1 Global Cyclosporine A API Sales Market Share by Purity (2017-2022)
2.3.2 Global Cyclosporine A API Revenue and Market Share by Purity (2017-2022)
2.3.3 Global Cyclosporine A API Sale Price by Purity (2017-2022)
2.4 Cyclosporine A API Segment by Application
2.4.1 Medical Pharmaceutical
2.4.2 Scientific Research
2.5 Cyclosporine A API Sales by Application
2.5.1 Global Cyclosporine A API Sale Market Share by Application (2017-2022)
2.5.2 Global Cyclosporine A API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Cyclosporine A API Sale Price by Application (2017-2022)
3 Global Cyclosporine A API by Company
3.1 Global Cyclosporine A API Breakdown Data by Company
3.1.1 Global Cyclosporine A API Annual Sales by Company (2020-2022)
3.1.2 Global Cyclosporine A API Sales Market Share by Company (2020-2022)
3.2 Global Cyclosporine A API Annual Revenue by Company (2020-2022)
3.2.1 Global Cyclosporine A API Revenue by Company (2020-2022)
3.2.2 Global Cyclosporine A API Revenue Market Share by Company (2020-2022)
3.3 Global Cyclosporine A API Sale Price by Company
3.4 Key Manufacturers Cyclosporine A API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cyclosporine A API Product Location Distribution
3.4.2 Players Cyclosporine A API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cyclosporine A API by Geographic Region
4.1 World Historic Cyclosporine A API Market Size by Geographic Region (2017-2022)
4.1.1 Global Cyclosporine A API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Cyclosporine A API Annual Revenue by Geographic Region
4.2 World Historic Cyclosporine A API Market Size by Country/Region (2017-2022)
4.2.1 Global Cyclosporine A API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Cyclosporine A API Annual Revenue by Country/Region
4.3 Americas Cyclosporine A API Sales Growth
4.4 APAC Cyclosporine A API Sales Growth
4.5 Europe Cyclosporine A API Sales Growth
4.6 Middle East & Africa Cyclosporine A API Sales Growth
5 Americas
5.1 Americas Cyclosporine A API Sales by Country
5.1.1 Americas Cyclosporine A API Sales by Country (2017-2022)
5.1.2 Americas Cyclosporine A API Revenue by Country (2017-2022)
5.2 Americas Cyclosporine A API Sales by Purity
5.3 Americas Cyclosporine A API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cyclosporine A API Sales by Region
6.1.1 APAC Cyclosporine A API Sales by Region (2017-2022)
6.1.2 APAC Cyclosporine A API Revenue by Region (2017-2022)
6.2 APAC Cyclosporine A API Sales by Purity
6.3 APAC Cyclosporine A API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cyclosporine A API by Country
7.1.1 Europe Cyclosporine A API Sales by Country (2017-2022)
7.1.2 Europe Cyclosporine A API Revenue by Country (2017-2022)
7.2 Europe Cyclosporine A API Sales by Purity
7.3 Europe Cyclosporine A API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cyclosporine A API by Country
8.1.1 Middle East & Africa Cyclosporine A API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Cyclosporine A API Revenue by Country (2017-2022)
8.2 Middle East & Africa Cyclosporine A API Sales by Purity
8.3 Middle East & Africa Cyclosporine A API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cyclosporine A API
10.3 Manufacturing Process Analysis of Cyclosporine A API
10.4 Industry Chain Structure of Cyclosporine A API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cyclosporine A API Distributors
11.3 Cyclosporine A API Customer
12 World Forecast Review for Cyclosporine A API by Geographic Region
12.1 Global Cyclosporine A API Market Size Forecast by Region
12.1.1 Global Cyclosporine A API Forecast by Region (2023-2028)
12.1.2 Global Cyclosporine A API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cyclosporine A API Forecast by Purity
12.7 Global Cyclosporine A API Forecast by Application
13 Key Players Analysis
13.1 Hangzhou Longshine Bio-Tech
13.1.1 Hangzhou Longshine Bio-Tech Company Information
13.1.2 Hangzhou Longshine Bio-Tech Cyclosporine A API Product Offered
13.1.3 Hangzhou Longshine Bio-Tech Cyclosporine A API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Hangzhou Longshine Bio-Tech Main Business Overview
13.1.5 Hangzhou Longshine Bio-Tech Latest Developments
13.2 Hangzhou Zhongmei Huadong Pharmaceutical
13.2.1 Hangzhou Zhongmei Huadong Pharmaceutical Company Information
13.2.2 Hangzhou Zhongmei Huadong Pharmaceutical Cyclosporine A API Product Offered
13.2.3 Hangzhou Zhongmei Huadong Pharmaceutical Cyclosporine A API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Hangzhou Zhongmei Huadong Pharmaceutical Main Business Overview
13.2.5 Hangzhou Zhongmei Huadong Pharmaceutical Latest Developments
13.3 Zhejiang Ruibang Laboratories
13.3.1 Zhejiang Ruibang Laboratories Company Information
13.3.2 Zhejiang Ruibang Laboratories Cyclosporine A API Product Offered
13.3.3 Zhejiang Ruibang Laboratories Cyclosporine A API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Zhejiang Ruibang Laboratories Main Business Overview
13.3.5 Zhejiang Ruibang Laboratories Latest Developments
13.4 North China Pharmaceutical Huasheng Co Ltd.
13.4.1 North China Pharmaceutical Huasheng Co Ltd. Company Information
13.4.2 North China Pharmaceutical Huasheng Co Ltd. Cyclosporine A API Product Offered
13.4.3 North China Pharmaceutical Huasheng Co Ltd. Cyclosporine A API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 North China Pharmaceutical Huasheng Co Ltd. Main Business Overview
13.4.5 North China Pharmaceutical Huasheng Co Ltd. Latest Developments
13.5 ChemWerth Inc
13.5.1 ChemWerth Inc Company Information
13.5.2 ChemWerth Inc Cyclosporine A API Product Offered
13.5.3 ChemWerth Inc Cyclosporine A API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 ChemWerth Inc Main Business Overview
13.5.5 ChemWerth Inc Latest Developments
13.6 AbbVie Inc
13.6.1 AbbVie Inc Company Information
13.6.2 AbbVie Inc Cyclosporine A API Product Offered
13.6.3 AbbVie Inc Cyclosporine A API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 AbbVie Inc Main Business Overview
13.6.5 AbbVie Inc Latest Developments
13.7 Catalent Pharma Solutions
13.7.1 Catalent Pharma Solutions Company Information
13.7.2 Catalent Pharma Solutions Cyclosporine A API Product Offered
13.7.3 Catalent Pharma Solutions Cyclosporine A API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Catalent Pharma Solutions Main Business Overview
13.7.5 Catalent Pharma Solutions Latest Developments
13.8 Teva API
13.8.1 Teva API Company Information
13.8.2 Teva API Cyclosporine A API Product Offered
13.8.3 Teva API Cyclosporine A API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Teva API Main Business Overview
13.8.5 Teva API Latest Developments
13.9 Actavis Inc.
13.9.1 Actavis Inc. Company Information
13.9.2 Actavis Inc. Cyclosporine A API Product Offered
13.9.3 Actavis Inc. Cyclosporine A API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Actavis Inc. Main Business Overview
13.9.5 Actavis Inc. Latest Developments
13.10 Apotex Fermentation Inc.
13.10.1 Apotex Fermentation Inc. Company Information
13.10.2 Apotex Fermentation Inc. Cyclosporine A API Product Offered
13.10.3 Apotex Fermentation Inc. Cyclosporine A API Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Apotex Fermentation Inc. Main Business Overview
13.10.5 Apotex Fermentation Inc. Latest Developments
13.11 CKD Bio Corporation
13.11.1 CKD Bio Corporation Company Information
13.11.2 CKD Bio Corporation Cyclosporine A API Product Offered
13.11.3 CKD Bio Corporation Cyclosporine A API Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 CKD Bio Corporation Main Business Overview
13.11.5 CKD Bio Corporation Latest Developments
13.12 Concord Biotech
13.12.1 Concord Biotech Company Information
13.12.2 Concord Biotech Cyclosporine A API Product Offered
13.12.3 Concord Biotech Cyclosporine A API Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Concord Biotech Main Business Overview
13.12.5 Concord Biotech Latest Developments
13.13 JOYANG LABORATORIES
13.13.1 JOYANG LABORATORIES Company Information
13.13.2 JOYANG LABORATORIES Cyclosporine A API Product Offered
13.13.3 JOYANG LABORATORIES Cyclosporine A API Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 JOYANG LABORATORIES Main Business Overview
13.13.5 JOYANG LABORATORIES Latest Developments
13.14 Novartis Pharmaceuticals Corporation
13.14.1 Novartis Pharmaceuticals Corporation Company Information
13.14.2 Novartis Pharmaceuticals Corporation Cyclosporine A API Product Offered
13.14.3 Novartis Pharmaceuticals Corporation Cyclosporine A API Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Novartis Pharmaceuticals Corporation Main Business Overview
13.14.5 Novartis Pharmaceuticals Corporation Latest Developments
13.15 Tecoland Corporation
13.15.1 Tecoland Corporation Company Information
13.15.2 Tecoland Corporation Cyclosporine A API Product Offered
13.15.3 Tecoland Corporation Cyclosporine A API Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Tecoland Corporation Main Business Overview
13.15.5 Tecoland Corporation Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Cyclosporine A API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Cyclosporine A API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 0.95
Table 4. Major Players of 0.98
Table 5. Major Players of 0.99
Table 6. Major Players of Others
Table 7. Global Cyclosporine A API Sales by Purity (2017-2022) & (Tons)
Table 8. Global Cyclosporine A API Sales Market Share by Purity (2017-2022)
Table 9. Global Cyclosporine A API Revenue by Purity (2017-2022) & ($ million)
Table 10. Global Cyclosporine A API Revenue Market Share by Purity (2017-2022)
Table 11. Global Cyclosporine A API Sale Price by Purity (2017-2022) & (US$/Kg)
Table 12. Global Cyclosporine A API Sales by Application (2017-2022) & (Tons)
Table 13. Global Cyclosporine A API Sales Market Share by Application (2017-2022)
Table 14. Global Cyclosporine A API Revenue by Application (2017-2022)
Table 15. Global Cyclosporine A API Revenue Market Share by Application (2017-2022)
Table 16. Global Cyclosporine A API Sale Price by Application (2017-2022) & (US$/Kg)
Table 17. Global Cyclosporine A API Sales by Company (2020-2022) & (Tons)
Table 18. Global Cyclosporine A API Sales Market Share by Company (2020-2022)
Table 19. Global Cyclosporine A API Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Cyclosporine A API Revenue Market Share by Company (2020-2022)
Table 21. Global Cyclosporine A API Sale Price by Company (2020-2022) & (US$/Kg)
Table 22. Key Manufacturers Cyclosporine A API Producing Area Distribution and Sales Area
Table 23. Players Cyclosporine A API Products Offered
Table 24. Cyclosporine A API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Cyclosporine A API Sales by Geographic Region (2017-2022) & (Tons)
Table 28. Global Cyclosporine A API Sales Market Share Geographic Region (2017-2022)
Table 29. Global Cyclosporine A API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Cyclosporine A API Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Cyclosporine A API Sales by Country/Region (2017-2022) & (Tons)
Table 32. Global Cyclosporine A API Sales Market Share by Country/Region (2017-2022)
Table 33. Global Cyclosporine A API Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Cyclosporine A API Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Cyclosporine A API Sales by Country (2017-2022) & (Tons)
Table 36. Americas Cyclosporine A API Sales Market Share by Country (2017-2022)
Table 37. Americas Cyclosporine A API Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Cyclosporine A API Revenue Market Share by Country (2017-2022)
Table 39. Americas Cyclosporine A API Sales by Type (2017-2022) & (Tons)
Table 40. Americas Cyclosporine A API Sales Market Share by Purity (2017-2022)
Table 41. Americas Cyclosporine A API Sales by Application (2017-2022) & (Tons)
Table 42. Americas Cyclosporine A API Sales Market Share by Application (2017-2022)
Table 43. APAC Cyclosporine A API Sales by Region (2017-2022) & (Tons)
Table 44. APAC Cyclosporine A API Sales Market Share by Region (2017-2022)
Table 45. APAC Cyclosporine A API Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Cyclosporine A API Revenue Market Share by Region (2017-2022)
Table 47. APAC Cyclosporine A API Sales by Purity (2017-2022) & (Tons)
Table 48. APAC Cyclosporine A API Sales Market Share by Purity (2017-2022)
Table 49. APAC Cyclosporine A API Sales by Application (2017-2022) & (Tons)
Table 50. APAC Cyclosporine A API Sales Market Share by Application (2017-2022)
Table 51. Europe Cyclosporine A API Sales by Country (2017-2022) & (Tons)
Table 52. Europe Cyclosporine A API Sales Market Share by Country (2017-2022)
Table 53. Europe Cyclosporine A API Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Cyclosporine A API Revenue Market Share by Country (2017-2022)
Table 55. Europe Cyclosporine A API Sales by Type (2017-2022) & (Tons)
Table 56. Europe Cyclosporine A API Sales Market Share by Purity (2017-2022)
Table 57. Europe Cyclosporine A API Sales by Application (2017-2022) & (Tons)
Table 58. Europe Cyclosporine A API Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Cyclosporine A API Sales by Country (2017-2022) & (Tons)
Table 60. Middle East & Africa Cyclosporine A API Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Cyclosporine A API Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Cyclosporine A API Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Cyclosporine A API Sales by Purity (2017-2022) & (Tons)
Table 64. Middle East & Africa Cyclosporine A API Sales Market Share by Purity (2017-2022)
Table 65. Middle East & Africa Cyclosporine A API Sales by Application (2017-2022) & (Tons)
Table 66. Middle East & Africa Cyclosporine A API Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Cyclosporine A API
Table 68. Key Market Challenges & Risks of Cyclosporine A API
Table 69. Key Industry Trends of Cyclosporine A API
Table 70. Cyclosporine A API Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Cyclosporine A API Distributors List
Table 73. Cyclosporine A API Customer List
Table 74. Global Cyclosporine A API Sales Forecast by Region (2023-2028) & (Tons)
Table 75. Global Cyclosporine A API Sales Market Forecast by Region
Table 76. Global Cyclosporine A API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Cyclosporine A API Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Cyclosporine A API Sales Forecast by Country (2023-2028) & (Tons)
Table 79. Americas Cyclosporine A API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Cyclosporine A API Sales Forecast by Region (2023-2028) & (Tons)
Table 81. APAC Cyclosporine A API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Cyclosporine A API Sales Forecast by Country (2023-2028) & (Tons)
Table 83. Europe Cyclosporine A API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Cyclosporine A API Sales Forecast by Country (2023-2028) & (Tons)
Table 85. Middle East & Africa Cyclosporine A API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Cyclosporine A API Sales Forecast by Purity (2023-2028) & (Tons)
Table 87. Global Cyclosporine A API Sales Market Share Forecast by Purity (2023-2028)
Table 88. Global Cyclosporine A API Revenue Forecast by Purity (2023-2028) & ($ Millions)
Table 89. Global Cyclosporine A API Revenue Market Share Forecast by Purity (2023-2028)
Table 90. Global Cyclosporine A API Sales Forecast by Application (2023-2028) & (Tons)
Table 91. Global Cyclosporine A API Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Cyclosporine A API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Cyclosporine A API Revenue Market Share Forecast by Application (2023-2028)
Table 94. Hangzhou Longshine Bio-Tech Basic Information, Cyclosporine A API Manufacturing Base, Sales Area and Its Competitors
Table 95. Hangzhou Longshine Bio-Tech Cyclosporine A API Product Offered
Table 96. Hangzhou Longshine Bio-Tech Cyclosporine A API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 97. Hangzhou Longshine Bio-Tech Main Business
Table 98. Hangzhou Longshine Bio-Tech Latest Developments
Table 99. Hangzhou Zhongmei Huadong Pharmaceutical Basic Information, Cyclosporine A API Manufacturing Base, Sales Area and Its Competitors
Table 100. Hangzhou Zhongmei Huadong Pharmaceutical Cyclosporine A API Product Offered
Table 101. Hangzhou Zhongmei Huadong Pharmaceutical Cyclosporine A API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 102. Hangzhou Zhongmei Huadong Pharmaceutical Main Business
Table 103. Hangzhou Zhongmei Huadong Pharmaceutical Latest Developments
Table 104. Zhejiang Ruibang Laboratories Basic Information, Cyclosporine A API Manufacturing Base, Sales Area and Its Competitors
Table 105. Zhejiang Ruibang Laboratories Cyclosporine A API Product Offered
Table 106. Zhejiang Ruibang Laboratories Cyclosporine A API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 107. Zhejiang Ruibang Laboratories Main Business
Table 108. Zhejiang Ruibang Laboratories Latest Developments
Table 109. North China Pharmaceutical Huasheng Co Ltd. Basic Information, Cyclosporine A API Manufacturing Base, Sales Area and Its Competitors
Table 110. North China Pharmaceutical Huasheng Co Ltd. Cyclosporine A API Product Offered
Table 111. North China Pharmaceutical Huasheng Co Ltd. Cyclosporine A API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 112. North China Pharmaceutical Huasheng Co Ltd. Main Business
Table 113. North China Pharmaceutical Huasheng Co Ltd. Latest Developments
Table 114. ChemWerth Inc Basic Information, Cyclosporine A API Manufacturing Base, Sales Area and Its Competitors
Table 115. ChemWerth Inc Cyclosporine A API Product Offered
Table 116. ChemWerth Inc Cyclosporine A API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 117. ChemWerth Inc Main Business
Table 118. ChemWerth Inc Latest Developments
Table 119. AbbVie Inc Basic Information, Cyclosporine A API Manufacturing Base, Sales Area and Its Competitors
Table 120. AbbVie Inc Cyclosporine A API Product Offered
Table 121. AbbVie Inc Cyclosporine A API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 122. AbbVie Inc Main Business
Table 123. AbbVie Inc Latest Developments
Table 124. Catalent Pharma Solutions Basic Information, Cyclosporine A API Manufacturing Base, Sales Area and Its Competitors
Table 125. Catalent Pharma Solutions Cyclosporine A API Product Offered
Table 126. Catalent Pharma Solutions Cyclosporine A API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 127. Catalent Pharma Solutions Main Business
Table 128. Catalent Pharma Solutions Latest Developments
Table 129. Teva API Basic Information, Cyclosporine A API Manufacturing Base, Sales Area and Its Competitors
Table 130. Teva API Cyclosporine A API Product Offered
Table 131. Teva API Cyclosporine A API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 132. Teva API Main Business
Table 133. Teva API Latest Developments
Table 134. Actavis Inc. Basic Information, Cyclosporine A API Manufacturing Base, Sales Area and Its Competitors
Table 135. Actavis Inc. Cyclosporine A API Product Offered
Table 136. Actavis Inc. Cyclosporine A API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 137. Actavis Inc. Main Business
Table 138. Actavis Inc. Latest Developments
Table 139. Apotex Fermentation Inc. Basic Information, Cyclosporine A API Manufacturing Base, Sales Area and Its Competitors
Table 140. Apotex Fermentation Inc. Cyclosporine A API Product Offered
Table 141. Apotex Fermentation Inc. Cyclosporine A API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 142. Apotex Fermentation Inc. Main Business
Table 143. Apotex Fermentation Inc. Latest Developments
Table 144. CKD Bio Corporation Basic Information, Cyclosporine A API Manufacturing Base, Sales Area and Its Competitors
Table 145. CKD Bio Corporation Cyclosporine A API Product Offered
Table 146. CKD Bio Corporation Cyclosporine A API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 147. CKD Bio Corporation Main Business
Table 148. CKD Bio Corporation Latest Developments
Table 149. Concord Biotech Basic Information, Cyclosporine A API Manufacturing Base, Sales Area and Its Competitors
Table 150. Concord Biotech Cyclosporine A API Product Offered
Table 151. Concord Biotech Cyclosporine A API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 152. Concord Biotech Main Business
Table 153. Concord Biotech Latest Developments
Table 154. JOYANG LABORATORIES Basic Information, Cyclosporine A API Manufacturing Base, Sales Area and Its Competitors
Table 155. JOYANG LABORATORIES Cyclosporine A API Product Offered
Table 156. JOYANG LABORATORIES Cyclosporine A API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 157. JOYANG LABORATORIES Main Business
Table 158. JOYANG LABORATORIES Latest Developments
Table 159. Novartis Pharmaceuticals Corporation Basic Information, Cyclosporine A API Manufacturing Base, Sales Area and Its Competitors
Table 160. Novartis Pharmaceuticals Corporation Cyclosporine A API Product Offered
Table 161. Novartis Pharmaceuticals Corporation Cyclosporine A API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 162. Novartis Pharmaceuticals Corporation Main Business
Table 163. Novartis Pharmaceuticals Corporation Latest Developments
Table 164. Tecoland Corporation Basic Information, Cyclosporine A API Manufacturing Base, Sales Area and Its Competitors
Table 165. Tecoland Corporation Cyclosporine A API Product Offered
Table 166. Tecoland Corporation Cyclosporine A API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 167. Tecoland Corporation Main Business
Table 168. Tecoland Corporation Latest Developments
List of Figures
Figure 1. Picture of Cyclosporine A API
Figure 2. Cyclosporine A API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cyclosporine A API Sales Growth Rate 2017-2028 (Tons)
Figure 7. Global Cyclosporine A API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Cyclosporine A API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 0.95
Figure 10. Product Picture of 0.98
Figure 11. Product Picture of 0.99
Figure 12. Product Picture of Others
Figure 13. Global Cyclosporine A API Sales Market Share by Purity in 2021
Figure 14. Global Cyclosporine A API Revenue Market Share by Purity (2017-2022)
Figure 15. Cyclosporine A API Consumed in Medical Pharmaceutical
Figure 16. Global Cyclosporine A API Market: Medical Pharmaceutical (2017-2022) & (Tons)
Figure 17. Cyclosporine A API Consumed in Scientific Research
Figure 18. Global Cyclosporine A API Market: Scientific Research (2017-2022) & (Tons)
Figure 19. Global Cyclosporine A API Sales Market Share by Application (2017-2022)
Figure 20. Global Cyclosporine A API Revenue Market Share by Application in 2021
Figure 21. Cyclosporine A API Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Cyclosporine A API Revenue Market Share by Company in 2021
Figure 23. Global Cyclosporine A API Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Cyclosporine A API Revenue Market Share by Geographic Region in 2021
Figure 25. Global Cyclosporine A API Sales Market Share by Region (2017-2022)
Figure 26. Global Cyclosporine A API Revenue Market Share by Country/Region in 2021
Figure 27. Americas Cyclosporine A API Sales 2017-2022 (Tons)
Figure 28. Americas Cyclosporine A API Revenue 2017-2022 ($ Millions)
Figure 29. APAC Cyclosporine A API Sales 2017-2022 (Tons)
Figure 30. APAC Cyclosporine A API Revenue 2017-2022 ($ Millions)
Figure 31. Europe Cyclosporine A API Sales 2017-2022 (Tons)
Figure 32. Europe Cyclosporine A API Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Cyclosporine A API Sales 2017-2022 (Tons)
Figure 34. Middle East & Africa Cyclosporine A API Revenue 2017-2022 ($ Millions)
Figure 35. Americas Cyclosporine A API Sales Market Share by Country in 2021
Figure 36. Americas Cyclosporine A API Revenue Market Share by Country in 2021
Figure 37. United States Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Cyclosporine A API Sales Market Share by Region in 2021
Figure 42. APAC Cyclosporine A API Revenue Market Share by Regions in 2021
Figure 43. China Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Cyclosporine A API Sales Market Share by Country in 2021
Figure 50. Europe Cyclosporine A API Revenue Market Share by Country in 2021
Figure 51. Germany Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Cyclosporine A API Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Cyclosporine A API Revenue Market Share by Country in 2021
Figure 58. Egypt Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Cyclosporine A API Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Cyclosporine A API in 2021
Figure 64. Manufacturing Process Analysis of Cyclosporine A API
Figure 65. Industry Chain Structure of Cyclosporine A API
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Global Graphitized Carbon Black (GCB) Ma..
Graphitized carbon black is a black particle that can be use..
+16467917070US (Toll Free)